Koers K2X Technology & Life Science, Inc.
Aandelen
KBPH
US5015722003
Financiële en goederenmarktoperatoren
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1 USD | -45,65% | -.--% | -.--% |
Omzet 2020 | 0,01 0,01 | Omzet 2021 | - | Marktkapitalisatie | 18,62 mln. 17,37 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | - 0 | Nettowinst (verlies) 2021 | - 0 | EV/omzet 2020 | 926.138.940 x |
Nettoliquiditeiten 2020 | 28,01K 26,12K | Nettoliquiditeiten 2021 | 8,26 mln. 7,7 mln. | EV/omzet 2021 | - |
K/w-verhouding 2020 |
-17
x | K/w-verhouding 2021 |
95
x | Werknemers | 1 |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 53,62% |
1 dag | -45,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Russo
CEO | Chief Executive Officer | 81 | 05-03-99 |
Director of Finance/CFO | 75 | 15-03-18 | |
Investor Relations Contact | - | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Paul Russo
CEO | Chief Executive Officer | 81 | 05-03-99 |
Peter Staple
BRD | Director/Board Member | 72 | 08-01-21 |
Jon Saxe
BRD | Director/Board Member | 88 | 08-01-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 16,33 mln. | |
+1,83% | 74,99 mld. | |
-6,12% | 41,2 mld. | |
-2,84% | 36,13 mld. | |
+3,34% | 34,83 mld. | |
-23,44% | 12,23 mld. | |
+7,44% | 9,4 mld. | |
-30,31% | 7,67 mld. | |
+13,76% | 7,4 mld. | |
-4,78% | 7,37 mld. |